The Federal Trade Commision on Tuesday filed a complaint against Shire ViroPharma, claiming the drugmaker abused government processes to prevent generic competition of its antibiotic Vancocin HCl from ...

Gift Article 10 Remaining As a subscriber, you have 10 articles to gift each month. Gifting allows recipients to access the article for free. AbbVie announced this morning it has settled litigation ...

The amount of generic rivals available in relation to a brand name treatment can affect drug costs, according to a report in the Journal of the American Medical Association. Researchers identified all ...

Patent thickets extend market exclusivity, delaying generic competition and increasing drug costs, with $3.5 billion in excess spending identified for four drugs over two years. The study found that ...

Generic drugmakers continue to face mounting pressure not only from pricing competition but also from Trump’s push for pharmaceutical import tariffs and the proposed “most-favored-nation” pricing ...

Generic drugmakers continue to navigate a challenging U.S. market defined by persistent price erosion, intense competition and structurally thin margins. While demand for generics remains steady, ...